Tumour Immunology Flashcards

1
Q

How can breast cancer be linked to the following symptoms: severe vertigo, unintelligible speech, truncal and appendicular ataxia?

A

Paraneoplastic cerebellar degeneration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain how breast cancer can lead to the degeneration of the cerebellum.

A

The antigen that the immune response is directed against is normally expressed in neural tissue
It is only expressed in breast tissue when there is a tumour
The abnormal expression of this antigen in the breast was noticed and an immune response was mounted, which then also reacted with the normal antigens in the neural tissue –> destruction of purkinje cells in the cerebellum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the cancer-immunity cycle.

A

Antigens are released from cancer cells and captured by APCs, which then migrate to local draining lymph nodes
If the environment is sufficiently inflammatory then there will be enough costimulation (inflammation allows expression of costimulatory molecules) then you will get activation of the T cell response
Once the T cells are activated they go back to the tumour – the processed antigens are then recognised by the T cells, which then kill the cancer cells
NOTE: this cycle is pretty similar to viral infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the effect of the PD-1 – PDL-1 signalling on the T cell response.

A

When a T cell has been exposed to an antigen several times, it starts to express PD-1 receptors
Tumour cells the upregulate expression of the PDL-1 ligand, which can bind to the PD-1 receptor and downregulate the T cell response
Blockade of the PD1-PDL1 interaction could help stimulate the T cell response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the main difference between tumours and viral infections with regards to the immune response?

A

Viral infections trigger a lot of inflammation, which causes upregulation of costimulatory molecules so an immune response can take place
Tumours do not cause very much inflammation, especially early on so they are more likely to be missed by the immune system and grow to a certain size before they can trigger a sufficiently inflammatory environment to trigger further immune responses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the requirements for activation of an adaptive anti-cancer immune response?

A

Local inflammation in the tumour

Expression and recognition of tumour antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the main problems with the immune surveillance of cancer?

A

It takes a tumour a while to cause inflammation

Antigenic differences between normal and tumour cells can be very subtle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which MHC class presents endogenous peptides?

A

MHC Class I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Give two examples of opportunistic malignancies.

A

EBV positive lymphoma (post-transplant immunosuppression)

HHV8 positive Kaposi sarcoma (occurs in HIV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give a few examples of viral infections that can cause cancer inimmunocompetent individuals.

A

HTLV1 associated leukaemia/lymphoma
HepB virus- and HepC virus-associated hepatocellular carcinoma
HPV positive genital tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which oncoproteins of HPV are responsible for the induction andmaintenance of cervical cancer?

A

E6

E7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What proteins do the vaccines for HPV use?

A

Structural proteins are used to generate virus particles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give an example of an HPV vaccine.

A

Gardasil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the two different times at which vaccines can be given?

A
Preventative vaccination (before the disease) 
Therapeutic vaccination (try to control the disease once it has occurred)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are tumour-associated antigens?

A

Tumour-associated antigens (TAA) derive from normal cellular proteins which are aberrantly expressed along with cancer (either aberrantly expressed in terms of timing (eg normally expressed in embryo but is now expressed in adulthood), location or quantity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Give examples of tumour-associated antigens.

A

Cancer-testis antigens – silent in normal adult tissues except male germ cells
eg MAGE family (a type of cancer testis antigen)– melanoma-associated antigens – identified in melanoma, also expressed in other tumours

others:
HER 2 
TAAs in PROSTATE cancer- 
prostate-specific antigen (PSA)
prostate-specific membrane antigen (PSMA)
prostatic acid phosphatase (PAP)
17
Q

When is p53 considered a tumour-associated antigen and when isit considered a tumour specific antigen?

A

Tumour-associated antigen – when it is over-expressed

Tumour specific antigen – when it becomes mutated

18
Q

Describe the problem with tolerance in cancer immunotherapy.

A

T cells that react strongly with self are deleted (central tolerance) so most people have tolerance against tumour-associated antigens

19
Q

What are the two major obstacles for the targeting of tumour-associated antigens in immunotherapy of cancer?

A
  • Autoimmune responses against normal tissues happens when you target TAA
  • to break the Immunological tolerance is difficult in the first place
20
Q

What are 4 main possible approaches to tumour immunotherapy?

A

Antibody-based therapy
Therapeutic vaccination
Immune checkpoint blockade
Adoptive transfer of immune cells

21
Q

Outline how Ab therapy can be used against tumours

A
  1. Abs targetting Tumour associated antigens eg Anti-HER 2 Antibodies
  2. link Ab with a drug or radioactive molecule to bring it close to the cancer cell to kill it
  3. Bispecific antibodies: eg in B cell tumours, we can use antibodies specific to T and B cells. Therefore brings T cells close to the mutated B cells and allow T cells to kill them
22
Q

Give an example of therapeutic vaccination used in prostate cancer

A

Name= Provenge® for advanced prostate cancer

Patient’s own WBC are treated with a fusion protein between prostatic acid phosphatase (PAP, slide 37) and the cytokine GM-CSF

Stimulates DC maturation and enhances PAP-specific T cell responses

23
Q

Give examples of targets used in therapies centered around immune checkpoint blockade

A

antibodies blocking PD-1 and CTLA-4

24
Q

What is adoptive cell transfer?

A
slide 51
main idea:
1. Take T cells out
2. Strengthen them in some way
3. Culture/grow
4. put them back into patient